- Contractors
- Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation
Federal contractor · Pharmaceutical Preparation Manufacturing
Novartis Pharmaceuticals has 47 federal contracts of $100,000 or more active since October 2023, with $80M obligated, from 4 agencies. 21 are still running, 21 ending within 18 months.
- Contracts
- 47 since FY2024$79,959,999 obligated, contracts of $100,000 or more
- Running now
- 21 contracts23 ended in the last 12 months
- Biggest customer
- Department of Veterans Affairs$54.7M on 37 contracts
- Main industry
- Pharmaceutical Preparation ManufacturingNAICS 325412
- UEI
- NG61ZA8TADW3Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2025 | $12,792,956 |
| FY2026 | $42,380,931 |
| FY2027 | $8,451,337 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Emergency Pluvicto and LutatheraDepartment of Veterans Affairs · 36C26227N0156 | $769,497 | Nov 30, 2026within a month | NJ |
| Radiopharmaceuticals Pluvicto / LutatheraDepartment of Veterans Affairs · 36C25026N0310 | $2,423,133 | Dec 31, 2026in 1 month | NJ |
| Radiopharmaceuticals-Lutathera and Pluvicto InjectionsDepartment of Veterans Affairs · 36C24426F0063 | $1,980,571 | Dec 31, 2026in 1 month | PA |
| Pluvicto Delivery OrderDepartment of Veterans Affairs · 36C26226F0314 | $823,062 | Dec 31, 2026in 1 month | CA |
| 26AP2812 - Pluvicto - Cleveland VamcDepartment of Veterans Affairs · 36C25026N0416 | $617,297 | Dec 31, 2026in 1 month | NJ |
| Pluvicto 2026 ClevelandDepartment of Veterans Affairs · 36C25026F0204 | $501,670 | Dec 31, 2026in 1 month | NJ |
| VA Gla NetspotDepartment of Veterans Affairs · 36C26226N0271 | $160,623 | Dec 31, 2026in 1 month | FL |
| Pluvicto (Lutetium Lu 177 Vipivotide Tetra 27MCI/Ml)Department of Veterans Affairs · 36C26226F0048 | $1,646,124 | Jan 1, 2027in 1 month | AZ |
| Pluvicto SuppliesDepartment of Veterans Affairs · 36C25526N0394 | $891,651 | Feb 5, 2027in 2 months | MO |
| LU177 - Pluvicto/LutatheraDepartment of Veterans Affairs · 36C25726N0205 | $4,162,659 | Feb 6, 2027in 2 months | NJ |
| PluvictoDepartment of Veterans Affairs · 36C24125F0148 | $810,281 | Mar 14, 2027in 3 months | CT |
| Bpa for Pluvicto and Lutathera InjectionDefense Health Agency · HT941026FE110 | $205,766 | Apr 30, 2027in 5 months | NJ |
| PluvictoDepartment of Veterans Affairs · 36C25725N0376 | $857,357 | Jun 30, 2027in 7 months | NJ |
| Delivery Order for a Base Plus One (1) Option Year for the Radiopharmaceutical Pluvicto.Department of Veterans Affairs · 36C25225F0191 | $1,733,030 | Aug 31, 2027in 9 months | NJ |
| PluvictoDepartment of Veterans Affairs · 36C24126F0136 | $2,537,775 | Sep 29, 2027in 10 months | CT |
| Pluvicto Ndc: 69488-0010-61Department of Veterans Affairs · 36C26127N0063 | $4,115,311 | Sep 30, 2027in 10 months | NJ |
| Pluvcito Ndc: 69488-0010-61Department of Veterans Affairs · 36C26127N0055 | $1,851,890 | Sep 30, 2027in 10 months | NJ |
| Lutathera Cancer TherapyDepartment of Veterans Affairs · 36C26126F0008 | $1,348,841 | Sep 30, 2027in 10 months | NJ |
| PluvictoDepartment of Veterans Affairs · 36C25027N0038 | $1,303,182 | Sep 30, 2027in 10 months | NJ |
| Lutathera Lu 177 DotateDepartment of Veterans Affairs · 36C26127F0023 | $250,835 | Sep 30, 2027in 10 months | NJ |
| Netspot - Ga-68 DotatateDepartment of Veterans Affairs · 36C24827N0026 | $160,623 | Sep 30, 2027in 10 months | NJ |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Department of Veterans Affairs37 contracts | $54,668,482 | |
| Office of Assistant Secretary for Preparedness and Response1 contract | $16,334,775 | |
| Department of the Army2 contracts | $6,619,099 | |
| Defense Health Agency7 contracts | $2,337,644 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Pharmaceutical Preparation ManufacturingNAICS 325412 · 46 contracts | $63,625,225 | |
| Research and Development in BiotechnologyNAICS 541711 · 1 contract | $16,334,775 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| New Jersey32 contracts | $59,676,541 | |
| Texas2 contracts | $6,619,099 | |
| Connecticut2 contracts | $3,348,056 | |
| Missouri2 contracts | $2,657,089 | |
| California2 contracts | $2,023,361 | |
| Pennsylvania1 contract | $1,980,571 | |
| Arizona1 contract | $1,646,124 | |
| Maryland3 contracts | $1,483,015 | |
| Illinois1 contract | $365,521 | |
| Florida1 contract | $160,623 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Department of Veterans Affairs: see the list.
Get new notices like Novartis Pharmaceuticals's work
New contract opportunities under NAICS 325412, pharmaceutical preparation manufacturing, the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy